Home BSC‎ > ‎Symposia‎ > ‎Speakers‎ > ‎

Ringelstein, Bernd

Prof.  E.  B.  Ringelstein  received  his  undergraduate  training  at  the  University  of Mainz.  After  graduation  as  Medical  Doctor  in  1973,  he  started  his  career  in neurology  at  the  University  of  Mainz.  Then  he  completed  a  neuropathology fellowship  at  the  same  University.  Thereafter  he  had  to  join  military  service  as  a doctor  and  captain.  He  continued  his  career  with  a  two-year  psychiatry  training  in 1978/79, and joined neurology again in 1980 in Aachen, where he became Assistant Professor  in  1986.  He  is  boarded  in  both  disciplines  psychiatry  and  neurology.  He passed fellowships and sabbaticals in Neuropathology in Mainz, in Clinical Neurology and   Hematology   at   Scripps   Clinic   and   Research   Foundation,   La   Jolla,   in Neurosonology  at  Bowman  Gray  School  of  Medicine,  Winston-Salem,  NC  and  in Epileptology  at  the  University  Hospital  of  Bonn.  He  was  appointed  Professor  and Chairman of the University Department of Neurology in Münster in 1992, a position he has held since then. Prof. Ringelstein’s basic and clinical research interests are in the  field  of  neurovascular  diseases,  in  particular  in  neurosonology,  neuroimaging, acute  stroke  and  cerebral  small  vessel  diseases.  He  has  authored  or  co-authored
more than 400 articles in peer review journals, and he has edited several books. He has  been  appointed  Honorary  Member  of  the  Austrian  Stroke  Working  Group  and has  been  appointed  Honorary  Doctor  Degree  (Dr.  h.  c.)  of  the  University  of Debrecen,  Hungary.  He  has  been  the  President  of  national  and  international scientific meetings. He received the Hugo-Spatz-Price from the German Neurological Society in 1992, and the “Erb-Becher” in 2008 from the same society for his merits in cerebrovascular  research,  and  for  building  up  the  German  stroke  unit  system, respectively. 
He has been involved as member of steering committees or data safety  monitoring boards  in  numerous  international  multicentre  therapeutic  trials  in  clinical  stroke research. 
Prof.  Ringelstein  was  President  of  the  German  Stroke  Society,  President  of  the European  Society  on  Neurosonology  and  Cerebral  Hemodynamics  (ESNCH),  and  he serves  or  has  served  on  the  Executive  Boards  of  the  ESNCH,  the  Neurosonology Research Group of the WFN, and the European Stroke Council. He is member of the European Stroke Organisation (ESO) Board of Directors. He also serves or has served on the Editorial Boards of international journals.
Comments